On Tuesday, Guardant Health Inc (NASDAQ: GH) opened higher 2.72% from the last session, before settling in for the closing price of $46.98. Price fluctuations for GH have ranged from $15.81 to $49.86 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 27.46%. Company’s average yearly earnings per share was noted 20.26% at the time writing. With a float of $117.73 million, this company’s outstanding shares have now reached $123.16 million.
Let’s determine the extent of company efficiency that accounts for 1779 employees. In terms of profitability, gross margin is 81.07%, operating margin of -74.41%, and the pretax margin is -74.02%.
Guardant Health Inc (GH) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Guardant Health Inc is 4.72%, while institutional ownership is 102.92%. The most recent insider transaction that took place on Jan 17 ’25, was worth 4,359. In this transaction Director of this company sold 116 shares at a rate of $37.58, taking the stock ownership to the 2,944 shares. Before that another transaction happened on Jan 17 ’25, when Company’s Director proposed sale 116 for $37.58, making the entire transaction worth $4,359.
Guardant Health Inc (GH) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.87% during the next five years compared to -8.88% drop over the previous five years of trading.
Guardant Health Inc (NASDAQ: GH) Trading Performance Indicators
Check out the current performance indicators for Guardant Health Inc (GH). In the past quarter, the stock posted a quick ratio of 5.85. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.24, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.90 in one year’s time.
Technical Analysis of Guardant Health Inc (GH)
Looking closely at Guardant Health Inc (NASDAQ: GH), its last 5-days average volume was 2.89 million, which is a jump from its year-to-date volume of 2.64 million. As of the previous 9 days, the stock’s Stochastic %D was 82.96%. Additionally, its Average True Range was 2.47.
During the past 100 days, Guardant Health Inc’s (GH) raw stochastic average was set at 94.62%, which indicates a significant increase from 89.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 87.58% in the past 14 days, which was higher than the 63.62% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $35.57, while its 200-day Moving Average is $28.01. However, in the short run, Guardant Health Inc’s stock first resistance to watch stands at $48.80. Second resistance stands at $49.33. The third major resistance level sits at $50.38. If the price goes on to break the first support level at $47.22, it is likely to go to the next support level at $46.17. Now, if the price goes above the second support level, the third support stands at $45.64.
Guardant Health Inc (NASDAQ: GH) Key Stats
There are currently 123,555K shares outstanding in the company with a market cap of 5.96 billion. Presently, the company’s annual sales total 563,950 K according to its annual income of -479,450 K. Last quarter, the company’s sales amounted to 191,480 K and its income totaled -107,750 K.
